Medivir: Targets Start of Combination Trial in Liver Cancer in Current Year
Research Note
2021-03-25
14:55
Redeye is encouraged by the news that the MIV-818 Phase Ib monotherapy trial is nearing completion.
NE
Niklas Elmhammer
Disclosures and disclaimers